Stephanie Okey
Vermögen: 923 459 $ am 30.06.2026
Vermögen: 923 459 $ am 30.06.2026
Ms. Stephanie S.
Okey is an Independent Director at Crinetics Pharmaceuticals, Inc. and an Independent Director at PTC Therapeutics, Inc. She is on the Board of Directors at Crinetics Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Ms. Okey was previously employed as an Independent Director by Catalent, Inc., an Independent Director by Albireo Pharma, Inc., and a GM-Rare Disease Business Unit & Senior VP by Genzyme Corp.
She also served on the board at Orphazyme A/S and California Life Sciences Association.
She received her undergraduate degree from The Ohio State University and a graduate degree from Wright State University (Ohio).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 5’667 ( 0.01% ) | 462 257 $ | 30.06.2026 | |
| 18.06.2026 | 12’325 ( 0.01% ) | 461 202 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PTC THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.12.2018 |
| CRINETICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.07.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| CATALENT, INC. | Direktor/Vorstandsmitglied | 18.12.2024 |
| ALBIREO PHARMA, INC. | Direktor/Vorstandsmitglied | 02.03.2023 |
| STRATEGIC PARTNERS A/S | Direktor/Vorstandsmitglied | 23.05.2022 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Direktor/Vorstandsmitglied | 01.01.2016 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.07.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wright State University (Ohio)
Wright State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Catalent, Inc.
Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen